Kessler J A, Black I B
Brain Res. 1981 Mar 9;208(1):135-45. doi: 10.1016/0006-8993(81)90626-0.
Development of the putative neurotransmitter, substance P (SP), in the embryonic rat dorsal root ganglion (DRG) and spinal cord was defined in vivo. SP was not detectable by radioimmunoassay before day 17 of gestation (E17). On E17, cervical sensory ganglia contained 4 pg SP/ganglion, rising to 49 pg/ganglion at birth. The dorsal cervical spinal cord contained 0.75 ng SP/mg protein on E17, rising to 6 ng SP/mg protein on postnatal day 3. The ventral spinal cord contained approximately 20% of the SP content in the dorsal cord at each gestational age. Intrauterine forelimb amputation partially prevented the normal development increase of SP in sensory ganglia destined to innervate that limb, suggesting that target structures regulate the development of peptidergic neruons. Conversely, treatment with nerve growth factor (NGF) stimulated development of SP in the DRG. Moreover, NGF treatment increased SP in the dorsal spinal cord, suggesting that NGF can modulate development within the CNS, as well as peripheral structures. It is likely that the CNS effect reflects NGF peptidergic neruons. Conversely, treatment with nerve growth factor (NGF) stimulated development of SP in the DRG. Moreover, NGF treatment increased SP in the dorsal spinal cord, suggesting that NGF can modulate development within the CNS, as well as peripheral structures. It is likely that the CNS effect reflects NGF peptidergic neruons. Conversely, treatment with nerve growth factor (NGF) stimulated development of SP in the DRG. Moreover, NGF treatment increased SP in the dorsal spinal cord, suggesting that NGF can modulate development within the CNS, as well as peripheral structures. It is likely that the CNS effect reflects NGF action on peripheral ganglia, but a direct effect on the spinal cord has not been excluded. However, treatment with antiserum to NGF failed to significantly inhibit development of ganglion SP. The system of SP-containing neurons in the DRG may provide a convenient model for defining events regulating peptidergic maturation.
在体内确定了假定神经递质P物质(SP)在胚胎大鼠背根神经节(DRG)和脊髓中的发育情况。在妊娠第17天(E17)之前,通过放射免疫测定法无法检测到SP。在E17时,颈感觉神经节含有4 pg SP/神经节,出生时升至49 pg/神经节。颈背脊髓在E17时含有0.75 ng SP/mg蛋白质,在出生后第3天升至6 ng SP/mg蛋白质。在每个胎龄时,腹侧脊髓中的SP含量约为背侧脊髓的20%。宫内前肢截肢部分阻止了注定要支配该肢体的感觉神经节中SP的正常发育增加,这表明靶结构调节肽能神经元的发育。相反,用神经生长因子(NGF)处理刺激了DRG中SP的发育。此外,NGF处理增加了背侧脊髓中的SP,这表明NGF可以调节中枢神经系统以及外周结构内的发育。中枢神经系统的作用可能反映了NGF对周围神经节的作用,但对脊髓的直接作用尚未排除。然而,用抗NGF血清处理未能显著抑制神经节SP的发育。DRG中含SP神经元的系统可能为定义调节肽能成熟的事件提供一个方便的模型。